Craneware plc (CRW.L)
| Previous close | 2,380.00 |
| Open | 0.00 |
| Bid | 2,340.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 0.00 - 0.00 |
| 52-week range | |
| Volume | |
| Avg. volume | 110,997 |
| Market cap | 833.569M |
| Beta (5Y monthly) | 0.13 |
| PE ratio (TTM) | 112.38 |
| EPS (TTM) | 0.21 |
| Earnings date | 04 Mar 2024 |
| Forward dividend & yield | 0.29 (1.22%) |
| Ex-dividend date | 21 Mar 2024 |
| 1y target est | 26.97 |
Simply Wall St.3 High Insider Ownership Growth Companies With Earnings Expanding By At Least 18%
As the United Kingdom's financial markets brace for the Bank of England's rate decision and eagerly await GDP growth figures, investor sentiment remains cautiously optimistic. In such a context, companies with high insider ownership can be particularly compelling, as they often reflect a management team deeply invested in the company’s success, aligning well with broader market growth expectations.
- Simply Wall St.
Investing in Craneware (LON:CRW) a year ago would have delivered you a 63% gain
Passive investing in index funds can generate returns that roughly match the overall market. But investors can boost...
PR NewswireThe Craneware Group Celebrates 25 Years of Success, Highlights Customer Commitment and Innovation as Keys to Longevity
This month, The Craneware Group, a leader in healthcare financial performance and 340B management, celebrates its 25th anniversary. Since 1999, they've partnered with US healthcare providers, enhancing operational efficiency and financial performance to deliver quality care. With their flagship chargemaster solution and comprehensive 340B offerings, they serve over 12,000 hospitals, clinics, and pharmacies. They're poised for growth, leveraging data from 200 million patient encounters and a $0.5
